FISH OIL REDUCES KIDNEY FAILURE RATE IN IgA NEPHROPATHY PATIENTS
This article was originally published in The Tan Sheet
Executive Summary
FISH OIL REDUCES KIDNEY FAILURE RATE IN IgA NEPHROPATHY PATIENTS treated for two years with supplements, according to a study by James Donadio, MD, Mayo Clinic, et al. published in the Nov. 3 issue of The New England Journal of Medicine. The authors concluded that "dietary fish-oil supplementation significantly slowed the rate of loss of renal function" in the 106-patient double-blind, placebo-controlled trial.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning